Morgan Stanley maintains Allegion at Equal-Weight, raises price target to $181 from $170

Morgan Stanley kept Allegion's rating at Equal-Weight but increased its price target to $181 from $170, suggesting a 5.6% downside from the last close. Recent analyst targets for Allegion range from $183 to $206.

Original reporting
Published Nov 3, 2026, 5:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 5:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Morgan Stanley maintains Allegion at Equal-Weight, raises price target to $181 from $170 — source image
Decision brief

The 30-second read

$ALLEBullishLow
01

Why it matters

This is primarily a valuation update from one sell-side firm, not a company-specific operational or financial disclosure.

02

Market read

Useful for positioning around sell-side sentiment, but it is not a fresh fundamental catalyst.

03

What to watch

The article does not provide the thesis behind the PT change, so traders may discount the move if it lacks new fundamentals or if other analysts’ targets cluster near the same range.

Relevance 4/10Novelty 4/10Timing: today’s analyst note update

Background

The piece summarizes a Morgan Stanley analyst action on Allegion, including a maintained rating and an updated price target.

Company-level read

Ticker impact

$ALLEBullishMedium confidence
Context

Morgan Stanley maintained Allegion at Equal-Weight and raised its price target to $181 from $170, implying a new valuation view.

Expected impact

Mild upward bias as traders price in the higher target, with limited follow-through given the unchanged Equal-Weight rating.

Evidence & confidence

The article provides a specific, incremental analyst PT change and a stated rating maintenance, which typically moves the stock modestly unless accompanied by a strong upgrade or new fundamental catalyst.

Market effects

Limited read-through to the broader building products or commercial construction supply chain, since this is a single-name analyst target change.

No clear regional spillover indicated beyond US small/mid-cap industrial sentiment.

Minimal global relevance; the catalyst is analyst PT revision rather than macro or cross-border event.

Counterpoint

Because the rating is unchanged at Equal-Weight, the PT increase may not translate into sustained buying pressure if the market already expects similar valuation.

Key entities

  • Allegion

    US-listed building products company covered by Morgan Stanley; Equal-Weight maintained and price target raised to $181.

Related articles

$ALLEHigh

BofA upgrades Allegion stock rating on strong earnings outlook

BofA upgraded Allegion (ALLE) to Buy, raising its price target to $200. The stock rose to $176.52. The upgrade follows strong Q3 2026 earnings and raised guidance, with BofA citing accelerated Americas growth. Earnings per share estimates were increased for 2026-2028. Allegion reported Q3 EPS of $2.60 and revenue of $1.17 billion, both exceeding expectations.

$ALLEMed

Allegion PLC (ALLE) (Q3 2026) Earnings Call Highlights: Raised Full-Year Outlook

Allegion PLC (ALLE) reported Q3 2026 earnings, raising its full-year outlook despite challenges. International segment revenue declined slightly, with weak Western Europe performance. The company expects persistent inflation into 2027, requiring continued pricing actions. Americas non-residential segment grew high single digits, driven by volume and price. CEO John Stone expressed confidence in the Schlage brand and its integration with smart home providers.

$ALLEHigh

Allegion (ALLE) Q3 2026 Earnings Call Transcript

Allegion (ALLE) reported Q3 2026 revenue of $1.2B, up 9.6% YoY, with organic growth of 7.2%. The company raised its full-year revenue outlook to 9.5-10.5% and EPS to $9.05-$9.10, driven by strong Americas performance. It completed the $90M acquisition of Overly Door Company and invested $40M in Ambient.ai. Q3 EPS was $2.60, up 13% YoY. International segment saw slight organic decline due to Western Europe weakness.